The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort.

Tuesday's generic approval of the budesonide-formoterol inhaler was granted to Mylan Pharmaceuticals. For both asthma and COPD, the inhaler is used twice daily roughly 12 hours apart, typically in ...

Rhinocort Hayfever & Allergy Extra Strength Nasal Spray contains 64 micrograms of budesonide as the active ingredient per spray, and the following inactive ingredients: ...

Airsupra ® (albuterol/budesonide) is now available for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age ...

Rabe KF, Pizzichini E, Ställberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.

In the new trial, researchers found that combining budesonide and albuterol into one rescue inhaler appears to be the better approach. On average, the two-drug inhaler cut patients' risk of a ...

Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...

CyDex Pharmaceuticals announced the presentation of Phase 2 clinical trial results of its Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).

Rabe, KF, Pizzichini, E, Ställberg, B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.